Nanoparticle-delivered Therapeutic Agents Targeting the Tumor Microenvironment for Antitumor Therapy

被引:0
作者
Li, Xiao-Tong [1 ,2 ]
Peng, Hongmei [3 ]
He, Jian [1 ]
Zhang, Zhikun [1 ]
Gan, Lu [1 ]
Wu, Pan [1 ]
Zhong, Liping [1 ]
Zhao, Yongxiang [1 ]
Deng, Zhiming [3 ]
Huang, Yong [1 ,3 ]
机构
[1] Guangxi Med Univ, Natl Ctr Int Res Biotargeting Theranost, Collaborat Innovat Ctr Targeting Tumor Diag & The, Guangxi Key Lab Biotargeting Theranost,Guangxi Ta, Nanning 530021, Guangxi, Peoples R China
[2] Linfen Cent Hosp, Sci Res & Educ Dept, Linfen 041000, Shanxi, Peoples R China
[3] First Peoples Hosp Changde City, Changde 415000, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
CARCINOMA-ASSOCIATED FIBROBLASTS; DRUG-DELIVERY; CANCER-IMMUNOTHERAPY; MACROPHAGES; HYPOXIA; NANOMEDICINE; PROGRESSION; ANGIOGENESIS; ANTIBODY; CELLS;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In recent years, nanotechnology has been widely used in the field of tumor treatment. Some nanomedicine applications have been approved for tumor treatment, but nanomedicine has not so far demonstrated the anticipated therapeutic effect. In this process, the tumor microenvironment plays a major role. The tumor microenvironment is an internal environment that supports tumor occurrence, development, and metastasis. It is composed of tumor cells and related cells, intercellular substances, capillaries, and biomolecules that pervade both the tumor mass itself and its surrounding area. The tumor microenvironment can be a potential target for tumor treatment. Therefore, nano-antitumor therapy targeting the tumor microenvironment has received widespread attention. This therapy is based on the physiological characteristics of tumors that differ from those of normal tissues. The tumor microenvironment is used as a therapeutic target, and drugs are delivered to the tumor site through nanoparticles-enabled targeting to achieve fast, controllable, and efficient tumor killing. This article reviews basic research such as design principles and applications of nano-antitumor therapeutic strategies targeting the tumor microenvironment, providing a theoretical basis and new research ideas for tumor treatment.
引用
收藏
页码:93 / 107
页数:15
相关论文
共 115 条
[1]   Monoclonal antibody therapy of cancer [J].
Adams, GP ;
Weiner, LM .
NATURE BIOTECHNOLOGY, 2005, 23 (09) :1147-1157
[2]   Role of therapeutic agents on repolarisation of tumour-associated macrophage to halt lung cancer progression [J].
Aldawsari, Hibah M. ;
Gorain, Bapi ;
Alhakamy, Nabil A. ;
Md, Shadab .
JOURNAL OF DRUG TARGETING, 2020, 28 (02) :166-175
[3]   Novel peptide probes to assess the tensional state of fibronectin fibers in cancer [J].
Arnoldini, Simon ;
Moscaroli, Alessandra ;
Chabria, Mamta ;
Hilbert, Manuel ;
Hertig, Samuel ;
Schibli, Roger ;
Behe, Martin ;
Vogel, Viola .
NATURE COMMUNICATIONS, 2017, 8
[4]   Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity [J].
Bakos, Orneala ;
Lawson, Christine ;
Rouleau, Samuel ;
Tai, Lee-Hwa .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
[5]   Stromal fibroblasts in cancer initiation and progression [J].
Bhowmick, NA ;
Neilson, EG ;
Moses, HL .
NATURE, 2004, 432 (7015) :332-337
[6]   The hypoxic response of tumors is dependent on their microenvironment [J].
Blouw, B ;
Song, HQ ;
Tihan, T ;
Bosze, J ;
Ferrara, N ;
Gerber, HP ;
Johnson, RS ;
Bergers, G .
CANCER CELL, 2003, 4 (02) :133-146
[7]   Rationale Behind Targeting Fibroblast Activation Protein-Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy [J].
Brennen, W. Nathaniel ;
Isaacs, John T. ;
Denmeade, Samuel R. .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (02) :257-266
[8]   Regulation of cancer cell metabolism [J].
Cairns, Rob A. ;
Harris, Isaac S. ;
Mak, Tak W. .
NATURE REVIEWS CANCER, 2011, 11 (02) :85-95
[9]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[10]   Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment [J].
Casazza, A. ;
Di Conza, G. ;
Wenes, M. ;
Finisguerra, V. ;
Deschoemaeker, S. ;
Mazzone, M. .
ONCOGENE, 2014, 33 (14) :1743-1754